Xcout IntelSign inSubscribe

Baird Medical Investment Holdings Ltd

BDMDMedical DevicesGuangzhou, China

Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.

Subscribe to see Baird Medical Investment Holdings Ltd’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Baird Medical Investment Holdings Ltd at a glance

Baird Medical Investment Holdings Ltd is a medical devices company headquartered in Guangzhou, China. It is publicly listed (BDMD) with a market capitalisation of $22.8M. Xcout tracks 12 named people at Baird Medical Investment Holdings Ltd, including Haimei Wu (Chairwoman of the Board of Directors & Chief Executive Officer).

Industry
Medical Devices
Headquarters
Guangzhou, China
Market cap
$22.8M
Employees
148
Ticker
BDMD

Baird Medical Investment Holdings Ltd leadership

  • Haimei WuChairwoman of the Board of Directors & Chief Executive Officer
  • Mark S. SaxtonChief Executive Officer U.S. Subsidiary
  • Jie LiActing Chief Financial Officer
  • Rongjian LuChief Technology Officer & Deputy GM
  • Quan QiuChief Administrative Officer & Executive Director
  • Wei HouExecutive Director

6 more named people on record for Baird Medical Investment Holdings Ltd, with roles, board committees and tenure — see the full roster →

Baird Medical Investment Holdings Ltd competitors

A few of Baird Medical Investment Holdings Ltd's closest competitors — see the full list of competitors and alternatives →

BRONCUS-B02216 · Medical DevicesUnited States
68% matchPublic

Broncus Holding Corporation is a global medical technology company specializing in the development of interventional pulmonology products. Its market reach extends across Mainland China, the European Union, the United States, and other international territories. The company's innovative product lineup includes advanced navigation systems such as LungPoint Virtual Bronchoscopic Navigation, a sophisticated computer-assisted image-based software solution. It also offers LungPoint Plus, a system providing real-time airway guidance crucial for lung biopsies and other medical interventions, and LungPro, a virtual bronchoscopic navigation product that enables three-dimensional real-time guided transbronchial needle aspiration alongside proprietary parenchymal navigation. Beyond navigation, Broncus provides a suite of therapeutic products. These feature InterVapor, a targeted bronchoscopic thermal vapor ablation system designed to treat diseased, hyper-inflated lung segments. Additionally, it offers an RF Generator paired with an RF Ablation Catheter, forming a radiofrequency ablation system specifically developed to target lung cancer. The H-Marker, a pulmonary surgical marker, is another key offering. The company further supplies a range of specialized procedural devices, including the BioStarNeedle, a single-use ultrasound-guided aspiration needle for retrieving tissue samples, and the FleXNeedle, a versatile multipurpose biopsy needle. Complementing these are various bronchoscopic accessories like the Archimedes Sheath, a sterile, single-use flexible tube that serves as a working channel during bronchoscopic procedures. The Archimedes Dilation Balloon, another sterile, single-use flexible tube with a distal balloon, is used to dilate target lung tissue within the bronchial tree after insertion through a bronchoscope or sheath. Finally, the Steerable Sheath provides a steerable adjustment handle and an additional working channel. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.

Market cap$51M
Employees191
BRONCUS-B competitors & alternatives →

Get Baird Medical Investment Holdings Ltd's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Baird Medical Investment Holdings Ltd — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Baird Medical Investment Holdings Ltd in Xcout Intel

  • 12 named people with titles, LinkedIn and board committees
  • 1 corporate event with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →